Abstract
Introduction
Lymphadenopathy is an abnormal increase in size and/ or altered consistency of lymph nodes. It is a clinical manifestation of regional or systemic disease and serves as an excellent clue to the underlying disease. Cervical lymphadenopathy is a fairly common clinical presentation. It is often a diagnostic challenge to medical professionals. The present study try to give an idea to proceed with such cases and also, to give insight to the medical professional about the diagnostic outcome and role of FNAC (Fine needle Aspiration cytology ) among patients presented with cervical lymphadenopathy of more than 3 weeks duration. Cervical lymphadenopathy can be presented as isolated or as a part of generalized lymphadenopathy. The use of fine needle aspiration cytology (FNAC) in the investigation of lymphadenopathy has become an acceptable and widely practiced minimally invasive technique, which is safe, simple, rapid and relatively pain-free. FNAC is highly cost effective and accurate as a first line investigative technique with differential diagnosis including reactive hyperplasia/inflammatory conditions, 
Results

Many of our patients presented with cervical lymphadenopathy from June 2005 to November 2008.
FNAC has been done in cases of cervical lymphadenopathy of more than 3 weeks duration. 110 cases have been sent for FNAC. Out of 110 FNAC of cervical lymphadenopathy, 55 were non-specific lymphadenitis, 32 were tuberculosis, 12 were metastatic (with 2 occult primary), 6 were lymphomas (Immunocytochemistry proved ) and 5 were abscess. All 55 non-specific lymphadenopathy cases (FNAC report) underwent lymph node biopsy. Out of them 5 cases were consistent with tuberculosis , 1 was lymphoma and rest were reactive . For 3 cases, frozen section biopsy have been done. One was consistent with granulomatous disease and two cases were diagnosed as lymphoid hyperplasia. Both the lymphoid hyperplasia cases have been diagnosed as Castleman's disease after histopathology report. There were no systemic manifestations for both the cases.
Discussion
The well-defined role of FNAC in the investigation of lymphadenopathy has previously been studied 2 .In the context of granulomatous disorders, the possible aetiology is wide and the use of FNAC with other ancillary tests (microbiological, immunohistochemical, radiological, biochemical and special staining techniques) is useful for obtaining a definitive diagnosis 3 . In our study 32 cases (29.09%) were diagnosed as tuberculosis on FNAC. This has been recommended as of first line screening method in suspected malignancy 4 .In our study 18 cases have been diagnosed as malignancy on FNAC. Out of those 12 cases (10.9%) were metastatic and 6 cases (5.45%) were lymphoma. The presence of granulomata in an aspirate may indicate the presence of a neoplastic process. Granulomata may be encountered in both Hodgkin's disease and nonHodgkin's lymphoma, particularly T-cell lymphoma 4 .Hodgkin's lymphoma is characterised by the classic Reed-Sternberg cells in a background of sarcoid-like granulomata, reactive lymphoid cells and occasional eosinophils 5 .Occasionally, lymph nodes containing metastatic carcinoma may also show features of granulomata. Previous reports have been described in metastatic nasopharyngeal carcinoma, seminoma and malignant melanoma 6, 7 .Histologically, non-caseating granulomata composed of epithelioid histiocytes with multinucleated giant cells are seen, but these can be indistinguishable from granulomatous inflammation from other causes. A series by Michael et al 8 highlighted the difficulties encountered in making a definitive diagnosis of malignant neoplasm that mimics or occurs, in association with granulomata. In our study, out of 110 cases of cervical lympadenopathy 55 patients (50%) FNAC report was specific. Rest 55 patients (non-specific lymphadenitis) underwent lymph node biopsy of which 5 were tuberculosis and 1 was lymphoma. Rest 49 cases were reactive. So FNAC was conclusive in total (55+49) = 104 patients (94.5%). This is supported by Michael et al 8 and Reyes et al 9 . A suspicious clinical history of TB (pyrexia, night sweats, recent travel to endemic areas, no previous BCG vaccination) coupled with positive aspirate, blood, sputum or urine tests for AFB and good response to anti-tuberculous therapy supports the diagnosis of TB. One disadvantage is the inherent delay in culture result, but it is anticipated that as polymerase chain reaction and other amplification techniques become more common, detection time for the organism will shorten, improving the value of FNAC in clinical practice 9 .Although there is no single gold standard test, the important role of FNAC in histological diagnosis and its underutilisation was highlighted by Steel et al 10 .We agree with the authors that FNAC used in conjunction with clinical findings, radiological and laboratory investigations can be a cost effective method.
Conclusion
A significant number of cases of FNAC diagnosed granulomatous lymphadenitis have an identifiable underlying causal pathology. Our experience suggests that FNAC combined with clinical correlation is useful as a first line investigation. The high specificity of the technique helps to guide further investigation. It is also highly cost effective in the diagnosis of relapse in patients with malignancies.
